Immunization of Sheep Against Caseous Lymphadenitis

Abdel Wahab M. B, Shigidi M. T. A


The aim of this study was to evaluate the efficacy of various vaccines against caseous lymphadenitis in sheep. A culture of a local strain of Corynebacterium pseudotuberculosis CP41 N was produced using IBT bioreactor at pH 8, temperature 31 º C and dilution rate of 0.02 h­¹. The harvest was used to prepare five types of vaccines; The first was a killed whole cell vaccine containing 8mg bacterial dry weight / 0.5ml, the second was a  cell wall vaccine containing 3mg protein/ 0.5 ml,  the third was a toxoid vaccine containing 4 mg protein /0.5 ml, the fourth was the cell wall + the toxoid vaccine (3mg protein/ 0.5ml+ 4mg protein /0.5ml) and the fifth was the  killed whole cell + the toxoid vaccine (8mg bacterial dry weight /0.5ml + 4 mg protein/0.5ml). Saponin and aluminum hydroxide adjuvants were added in a concentration of 1mg/1ml dose each to the different vaccines. Each vaccine was injected subcutaneously in animals of one of 5 groups of sheep of 7 animals each, and animals in the sixth group were left as unvaccinated control. All animals were bled at weekly intervals for serological monitoring by the agglutination test. After four weeks, a booster dose of each vaccine as the 1st dose was given to the animals. Four weeks after the second dose of vaccine, all animals were challenged subcutaneously with 5.1X108 CFU of C. pseudotuberculosisCP41 N. The animals were then slaughtered four weeks later to determine the number of abscesses in the carcasses. The results showed that the vaccine which consisted of killed whole cells + the toxoid was the best of the five vaccines with a significant reduction (p<0.05) in mean abscess numbers in vaccinated animals after challenge with C. pseudotuberculosis. The percentage of protection of the group vaccinated with the killed whole cell+ the toxoid was 75% compared with  32.3%, 37.5%, 37.5% and 45.3% for the groups vaccinated with the cell wall lysate, the killed whole cell, the toxoid and the cell wall lysate + the toxoid vaccines,  respectively.


Sheep; caseous lymphadenitis; Corynebacterium pseudotuberculosis

Full Text:



Abdel Wahab, M. B. (2000). Toxin production by isolates of Corynebacterium pseudotuberculosis and development of a protective product. M. V. Sc. Thesis. University of Khartoum, Sudan.

Abdel Wahab, M. B. (2010). Trials for development of a vaccine against caseous lymphadenitis in Sheep. PhD Thesis. University of Khartoum, Sudan

Augustine, J. L., Richards, A. B. and Renshaw, H. W. (1982). Concentration ofCorynebacterium pseudotuberculosis obtained from lesions of sheep and goats with caseous lymphadenitis. Proceedings 3rd International Conference on Goat Production and Disease. Tuscon, Arizona. Arizona, p 525.

Bőhnel, H. (1999). Goettingen IBT bioreactor manual for bacterial antigen production.

Burrell, D. H. (1979). Conditions for in vitrohaemolytic activity by Corynebacterium ovis exotoxins. Res. Vet. Sci., 26: 333-338.

Eggleton, D. G., Hynes, J. A., Middleton, H. D. and Cox, J. C. (1991). Immunization against Ovine caseous lymphadenitis: Correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined Clostridial, Corynebacterical vaccines. Aust. Vet. J., 68 (10): 317-319.

Keskintepe, H. (1976). Stabilization of Corynebacterium ovis antigens for serum agglutination test. FiratUniv. Vet.FakDerg 3: 84-93.

Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951).Proteinmeasurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275.

Lund, A., Almlid, T., Larsen, H. J. and Steine, T. (1982). Antibodies to Corynebacterium pseudotuberculosis in adult goats from a naturally infected herd. Acta Vet. Scand., 23: 473-482.

Miles, A. A., Misra, S. S. and Irwin, J. O. (1938). The estimation of the bactericidal power of the blood. Epidemiology & Infection, 38(6), 732-749. Nairn, M.E.; Robertson, J.P. and McQuade, N.C. (1977).The control of caseous lymphadenitis in sheep by vaccination.Proc. 54thAnnu.Conf. Aust. Vet. Assoc.

Paton, M.W., Walker, S. B., Rose, I. R. and Watt G.F. (2003). Prevalence of caseous lymphadenitis and usage of caseous lymphadenitis vaccines in sheep flocks. Aust. Vet. J., 81: 91–95.

Shigidi, M. T. (1979). Comparison of five serological tests for the diagnosis of C.ovis infection in sheep. Brit. Vet. J., 132:172-177.

Suleiman, K. M. (2001). Investigations on production, quality control, and efficacy of vaccines against Corynebacterium pseudotuberculosis. PhD. thesis. Gőtt. Beitr. Land.-Forstwirt. Trop. Subtrop, Heft 145.Germany.

Williamson, L.H. (2001). Caseous lymphadenitis in small ruminants, Vet. Clin. North Am. Food Anim. Pract., 17: 359–371.


  • There are currently no refbacks.

ISSN: 243456

U. of  K. J. Vet. Med. Anim. Prod.